Madlener, Marie
Breuninger, Marianne
Meißner, Arne
Stetefeld, Henning
Telentschak, Sergej
Wille, Thorsten
van Eimeren, Thilo
Jung, Norma
Funding for this research was provided by:
Universitätsklinikum Köln
Article History
Received: 10 November 2022
Accepted: 14 December 2022
First Online: 29 December 2022
Declarations
:
: M. Madlener has no relevant financial or non-financial interests to disclose. M. Breuninger has no relevant financial or non-financial interests to disclose. A. Meißner has no relevant financial or non-financial interests to disclose. H. Stetefeld has no relevant financial or non-financial interests to disclose. S. Telentschak has no relevant financial or non-financial interests to disclose. T. Wille has no relevant financial or non-financial interests to disclose. T. van Eimeren has no relevant financial or non-financial interests to disclose. N. Jung has received lecture fees from Gilead, Infectopharm, MSD, Bayer and Labor Stein and travel grants from Gilead, Basilea, Correvio, Pfizer and Novartis and grants from an observational study from Infectofos.
: This case report was conducted following the 1964 Declaration of Helsinki and its subsequent amendments.
: The participant has consented to the submission of the case report to the journal.
: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.